Michelle Frazier

Michelle Frazier, Ph.D., possesses extensive experience in regulatory affairs within the biotechnology and pharmaceutical industries. Currently serving as Senior Vice President of Regulatory Affairs at Coya Therapeutics, Inc., Michelle has held executive positions as President of Innovative Global Regulatory Solutions, LLC, and Soigneur Regulatory Consulting, LLC, as well as Vice President of Regulatory Affairs at CytomX Therapeutics and Revance. Michelle Frazier earned a Ph.D. in Cell Biology from Loyola University Chicago and a B.S. in Microbiology from Washington State University.